PCRX Pacira Pharmaceuticals, Inc.

45.45
-0.85  -2%
Previous Close 46.30
Open 46.50
Price To book 6.85
Market Cap 1.82B
Shares 40,093,000
Volume 565,817
Short Ratio 3.93
Av. Daily Volume 923,792

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved October 31, 2011.
EXPAREL
Postsurgical pain
CRL March 2 2015. New Phase 3 trial initiated 1Q 2016. Enrollment to be completed early 2017.
EXPAREL
Single-dose injection femoral nerve block for total knee arthroplasty surgery

Latest News

  1. Pacira Pharmaceuticals Announces Resignation of James Scibetta
  2. ETFs with exposure to Pacira Pharmaceuticals, Inc. : May 22, 2017
  3. Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
  4. Paul Tudor Jones' Top 4 Health Care Buys
  5. Edited Transcript of PCRX earnings conference call or presentation 4-May-17 12:30pm GMT
  6. Pacira Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference
  7. Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US : May 8, 2017
  8. Pacira reports 1Q loss
  9. Pacira Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results
  10. Investor Network: Pacira Pharmaceuticals, Inc. to Host Earnings Call
  11. New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to Treat Postsurgical Pain if Given the Option
  12. Pacira Pharmaceuticals Announces Timing for First Quarter 2017 Financial Results Webcast and Conference Call
  13. Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US : April 25, 2017
  14. Can Pacira Pharmaceuticals' Exparel Reduce Opioid Abuse?
  15. Can Drugmakers Cure the Opioid Crisis?
  16. Pacira Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PCRX) : April 17, 2017
  17. Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PCRX-US : April 13, 2017
  18. Pacira Focuses on Lead Candidate Exparel's Label Expansion
  19. MonoSol Rx Appoints James S. Scibetta to Board of Directors
  20. Pacira Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference